KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Ginkgo Bioworks Holdings (DNA) Receivables - Other (2021 - 2025)

Ginkgo Bioworks Holdings' Receivables - Other history spans 5 years, with the latest figure at $14.5 million for Q4 2025.

  • For Q4 2025, Receivables - Other rose 28.32% year-over-year to $14.5 million; the TTM value through Dec 2025 reached $14.5 million, up 28.32%, while the annual FY2025 figure was $14.5 million, 28.32% up from the prior year.
  • Receivables - Other reached $14.5 million in Q4 2025 per DNA's latest filing, up from $11.3 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $14.5 million in Q4 2025 to a low of $300000.0 in Q2 2021.
  • Average Receivables - Other over 5 years is $6.7 million, with a median of $5.5 million recorded in 2021.
  • Peak YoY movement for Receivables - Other: skyrocketed 2066.67% in 2022, then rose 11.88% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $4.6 million in 2021, then crashed by 54.44% to $2.1 million in 2022, then skyrocketed by 382.1% to $10.1 million in 2023, then rose by 11.88% to $11.3 million in 2024, then grew by 28.32% to $14.5 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Receivables - Other are $14.5 million (Q4 2025), $11.3 million (Q4 2024), and $10.1 million (Q4 2023).